BR112013032426A2 - composições probióticas e métodos - Google Patents

composições probióticas e métodos

Info

Publication number
BR112013032426A2
BR112013032426A2 BR112013032426A BR112013032426A BR112013032426A2 BR 112013032426 A2 BR112013032426 A2 BR 112013032426A2 BR 112013032426 A BR112013032426 A BR 112013032426A BR 112013032426 A BR112013032426 A BR 112013032426A BR 112013032426 A2 BR112013032426 A2 BR 112013032426A2
Authority
BR
Brazil
Prior art keywords
methods
probiotic compositions
probiotic
compositions
Prior art date
Application number
BR112013032426A
Other languages
English (en)
Other versions
BR112013032426B1 (pt
Inventor
Andrea Budelli
Francesca Romana Fasano
Lorenzo Bramati
Miryam Terzano
Original Assignee
Heinz Co H J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heinz Co H J filed Critical Heinz Co H J
Publication of BR112013032426A2 publication Critical patent/BR112013032426A2/pt
Publication of BR112013032426B1 publication Critical patent/BR112013032426B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/127—Fermented milk preparations; Treatment using microorganisms or enzymes using microorganisms of the genus lactobacteriaceae and other microorganisms or enzymes, e.g. kefir, koumiss
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/127—Fermented milk preparations; Treatment using microorganisms or enzymes using microorganisms of the genus lactobacteriaceae and other microorganisms or enzymes, e.g. kefir, koumiss
    • A23C9/1275—Fermented milk preparations; Treatment using microorganisms or enzymes using microorganisms of the genus lactobacteriaceae and other microorganisms or enzymes, e.g. kefir, koumiss using only lactobacteriaceae for fermentation in combination with enzyme treatment of the milk product; using enzyme treated milk products for fermentation with lactobacteriaceae
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A23L7/104—Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/165—Paracasei
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
BR112013032426-0A 2011-06-20 2012-06-18 composição compreendendo um produto alimentício fermentado, método de produção de uma composição nutricional e uso de uma bactéria probiótica lactobacillus paracasei cba l74 BR112013032426B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161498910P 2011-06-20 2011-06-20
US61/498,910 2011-06-20
PCT/US2012/042959 WO2012177556A2 (en) 2011-06-20 2012-06-18 Probiotic compositions and methods

Publications (2)

Publication Number Publication Date
BR112013032426A2 true BR112013032426A2 (pt) 2016-11-08
BR112013032426B1 BR112013032426B1 (pt) 2021-02-09

Family

ID=47423159

Family Applications (2)

Application Number Title Priority Date Filing Date
BR112013032426-0A BR112013032426B1 (pt) 2011-06-20 2012-06-18 composição compreendendo um produto alimentício fermentado, método de produção de uma composição nutricional e uso de uma bactéria probiótica lactobacillus paracasei cba l74
BR132020021160A BR132020021160F1 (pt) 2011-06-20 2020-10-15 Composição compreendendo um fermentado de bactéria probiótica lactobacillus paracasei cba l74 e uso do mesmo

Family Applications After (1)

Application Number Title Priority Date Filing Date
BR132020021160A BR132020021160F1 (pt) 2011-06-20 2020-10-15 Composição compreendendo um fermentado de bactéria probiótica lactobacillus paracasei cba l74 e uso do mesmo

Country Status (17)

Country Link
US (4) US10039296B2 (pt)
EP (2) EP2734049B1 (pt)
JP (1) JP2014516589A (pt)
CN (1) CN103997899B (pt)
AU (1) AU2012273206B2 (pt)
BR (2) BR112013032426B1 (pt)
CA (1) CA2839524C (pt)
DK (1) DK2734049T3 (pt)
ES (1) ES2677850T3 (pt)
HK (1) HK1199694A1 (pt)
MX (1) MX352677B (pt)
MY (2) MY187589A (pt)
PL (1) PL2734049T3 (pt)
PT (1) PT2734049T (pt)
RU (2) RU2748839C2 (pt)
TR (1) TR201809987T4 (pt)
WO (1) WO2012177556A2 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8518903B2 (en) 2007-04-19 2013-08-27 University of Pittsburgh—of the Commonwealth System of Higher Education Use of toll-like receptor-9 agonists
US10668092B2 (en) 2010-09-24 2020-06-02 The John Hopkins University Compositions and methods for treatment of inflammatory disorders
US9072760B2 (en) 2010-09-24 2015-07-07 University of Pittsburgh—of the Commonwealth System of Higher Education TLR4 inhibitors for the treatment of human infectious and inflammatory disorders
WO2012088425A2 (en) 2010-12-22 2012-06-28 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Gap junction-enhancing agents for treatment of necrotizing enterocolitis and inflammatory bowel disease
ES2677850T3 (es) 2011-06-20 2018-08-07 H.J. Heinz Company Brands Llc Composiciones y métodos probióticos
ES2691087T3 (es) * 2012-06-18 2018-11-23 H.J. Heinz Company Brands Llc Trastornos relacionados con el gluten
WO2014052453A1 (en) * 2012-09-25 2014-04-03 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Oral therapy of necrotizing enterocolitis
MX2013012618A (es) * 2012-10-26 2016-05-26 María Del Carmen Cadena Garcia Método de manufactura de mezcla de granos fermentados.
CN110651824A (zh) 2013-05-10 2020-01-07 H.J.海因茨品牌有限责任公司 益生菌和使用方法
ITMI20131467A1 (it) 2013-09-06 2015-03-07 Sofar Spa Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico
CN104894021B (zh) * 2015-06-03 2018-02-09 宜兰食品工业股份有限公司 一种副干酪乳杆菌及其应用
JP6605319B2 (ja) * 2015-12-17 2019-11-13 株式会社ダイワ 乳酸菌含有加工食品の製造方法
MA45288A (fr) * 2016-06-08 2019-04-17 Sofar Spa Nouvelle utilisation médicale de probiotiques
IT201600081929A1 (it) * 2016-08-03 2018-02-03 St Europeo Di Oncologia S R L Uso del surnatante di lactobacillus paracasei nel trattamento della congiuntivite, in particolare della vernal cheratocongiuntivite
IT201600127498A1 (it) 2016-12-16 2018-06-16 Sofar Spa Probiotici per uso nella diverticolosi e malattia diverticolare
CN110741073A (zh) * 2017-06-09 2020-01-31 曾根农场股份公司 新乳酸菌及其用途
CN110891432A (zh) * 2017-07-31 2020-03-17 三菱商事生命科学株式会社 吞咽困难者用增粘组合物
CN109662259B (zh) * 2017-10-16 2022-07-29 江苏省农业科学院 一种富益生菌冻干毛豆粒产品及其制备方法
CN109864270B (zh) * 2017-12-01 2022-07-29 江苏省农业科学院 一种富益生菌冻干胡萝卜丁产品及其制备方法
WO2019157063A1 (en) * 2018-02-07 2019-08-15 White Dog Labs, Inc. An improved method for selecting microorganisms
JP2019149977A (ja) * 2018-03-05 2019-09-12 今野 由梨 ペット用サプリメント及びその製造方法
CN112534043B (zh) 2018-05-09 2024-04-26 Ko生物技术有限公司 副干酪乳杆菌菌株及其用途
WO2020229689A1 (en) * 2019-05-15 2020-11-19 N.V. Nutricia Fermented formula for improving intestinal development
CN112869169B (zh) * 2019-11-29 2023-07-18 内蒙古伊利实业集团股份有限公司 副干酪乳杆菌et-22提升肠道细菌感染抗性和肠道免疫力的应用
WO2024008597A1 (en) * 2022-07-04 2024-01-11 Alfasigma S.P.A. Fermentation product for the treatment of inflammatory diseases

Family Cites Families (120)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU555802B2 (en) 1983-07-01 1986-10-09 Microlife Technics, Inc. Fermented foods comprising lactic acid
US5635199A (en) 1995-10-27 1997-06-03 Nestec Ltd. Support of pediatric patients
RU2134583C1 (ru) 1996-02-29 1999-08-20 Санкт-Петербургская государственная педиатрическая медицинская академия Способ санации женщин с массивной микробной обсемененностью грудного молока
AU3173497A (en) 1996-06-21 1998-01-14 Quest International B.V. Fermentation of fruit products
ATE206873T1 (de) 1997-01-09 2001-11-15 Nestle Sa Probiotik enthaltendes getreideprodukt
DE69802413T3 (de) 1997-07-05 2009-07-16 Société des Produits Nestlé S.A. LACTOBACILLI ZUR ERHöHUNG DER MINERALIENABSORPTION DURCH DARMZELLEN
SE510813C2 (sv) * 1997-12-08 1999-06-28 Arla Ekonomisk Foerening Bakteriestam av arten Lactobacillus Paracasei subsp. paracasei, sammansättning därav för användning i livsmedel, samt produkt innehållande stammen
US6036985A (en) 1998-04-03 2000-03-14 Nestec S.A. Calcium complex and food fortified therewith
EP1034787A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
EP1034788A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactic acid bacteria strains capable of preventing diarrhea
SE522747C2 (sv) 1999-11-18 2004-03-02 Probi Ab Barnmatsprodukt
AU2001238285A1 (en) 2000-02-17 2001-08-27 Wyeth Nutritional formulation containing prebiotic substances
FI110668B (fi) 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
SE0003100D0 (sv) * 2000-09-01 2000-09-01 Probi Ab New strains
DE60143616D1 (de) 2000-10-06 2011-01-20 Oreal Verwendung von probiotischen milchsäure-produzierende bakterien zur zum schutz der haut gegen uv-induzierter allergischen reaktionen und entzündungskrankheiten oder immunsuppression
GB0027761D0 (en) 2000-11-14 2000-12-27 Nestle Sa Nutritional composition for an immune condition
KR100419132B1 (ko) * 2000-12-29 2004-02-18 조성근 위·장 점막 부착성과 증식성, 내산성, 내담즙성 및헬리코박터 파일로리, 대장균 0157:ｈ7에 대한 항균성이우수한 락토바실러스 파라카제이 서브스패시즈 파라카제이ｃｓｋ 01
US7303871B2 (en) 2002-02-14 2007-12-04 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for Celiac Sprue
UA77066C2 (en) 2002-02-21 2006-10-16 Nestle Sa Orally administrable composition for the photoprotection of the skin
EP1364586A1 (en) 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
DE60322570D1 (de) 2002-06-28 2008-09-11 Puleva Biotech Sa Probiotische stämme, verfahren zur ihren selektion, diese enthaltende zusammensetzungen und ihre verwendung
US8394370B2 (en) 2003-06-23 2013-03-12 Nestec S.A. Nutritional formula for optimal gut barrier function
ES2677868T3 (es) 2003-10-16 2018-08-07 Nestec S.A. Composición nutricional frente a los efectos secundarios de la quimioterapia o de la radioterapia
WO2005039319A2 (en) 2003-10-24 2005-05-06 N.V. Nutricia Synbiotic composition for infants
US7955834B2 (en) 2004-06-03 2011-06-07 Biogaia Ab Method for improved breast milk feeding to reduce the risk of allergy
EP1723951A1 (en) 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
EP1629850B2 (en) 2004-08-24 2013-05-22 N.V. Nutricia Nutritional composition comprising indigestible transgalactooligosaccharides and digestible galactose saccharides
AU2006217160B2 (en) 2005-02-28 2011-09-15 N.V. Nutricia Nutritional composition with probiotics
WO2006108824A1 (en) 2005-04-13 2006-10-19 Nestec S.A. Infant formula with probiotics
US20060233772A1 (en) 2005-04-15 2006-10-19 Udo Herz Method for preventing or treating the development of respiratory allergies
EP1714660A1 (en) 2005-04-21 2006-10-25 N.V. Nutricia Uronic acid and probiotics
US8075934B2 (en) 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
CN102894371A (zh) 2005-07-01 2013-01-30 努特里希亚公司 含水解的蛋白质的婴儿营养品
JP5242165B2 (ja) 2005-12-08 2013-07-24 キリンホールディングス株式会社 イソフムロン類包接体およびそれを含有する組成物
ES2381211T3 (es) 2006-02-15 2012-05-24 Nestec S.A. Uso del Bifidobacterium longum para prevenir y tratar inflamaciones
BRPI0708689A2 (pt) 2006-03-07 2011-06-07 Nestec Sa mistura simbiótica
PL1839495T3 (pl) 2006-03-27 2011-07-29 Nestec Sa Mrożone desery wzbogacone w białko
US20110165127A1 (en) * 2006-06-09 2011-07-07 Fabiola Masri Dairy-derived probiotic compositions and uses thereof
DE602007000193D1 (de) * 2006-07-07 2008-12-04 Alpro Nv Verfahren zur herstellung eines milchprodukt-analogs
ES2594656T3 (es) 2006-07-13 2016-12-21 Nestec S.A. Sistema de estabilizador para composiciones nutritivas líquidas
TW200814987A (en) 2006-08-08 2008-04-01 Nestec Sa Stable and bioavailable compositions of isomers of carotenoids for skin and hair
EP1917960A1 (en) 2006-11-06 2008-05-07 Nestec S.A. Improved biological effects of rosmarinic acid
EP1932437A1 (en) 2006-12-15 2008-06-18 Nestec S.A. Infant formula
ES2668552T3 (es) 2007-03-21 2018-05-18 Nestec S.A. Sistema de seguridad para composiciones nutricionales en polvo
EP1974735A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Reduction of risk of diarrhoea
EP1974734A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
EP1974743A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
WO2008153377A1 (en) 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
PT2036447E (pt) 2007-09-07 2010-03-23 Nestec Sa Processo para a produção de produtos alimentares para bebés
PL2187766T3 (pl) 2007-09-07 2014-03-31 Nestec Sa Szereg aseptycznie wytwarzanych produktów żywnościowych dla niemowląt mających niskie stężenie niepożądanych produktów ubocznych oraz sposób ich wytwarzania
EP2036568A1 (en) 2007-09-12 2009-03-18 Nestec S.A. Wolfberries and inflammation
WO2009060073A1 (en) 2007-11-08 2009-05-14 Nestec S.A. Use of oligosaccharides containing n-acetyllactosamine for maturation of immune responses in neonates
EP2060257A1 (en) 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
WO2009067000A1 (en) 2007-11-20 2009-05-28 N.V. Nutricia Composition with synbiotics
JP2011504365A (ja) 2007-11-26 2011-02-10 ネステク ソシエテ アノニム 乳児のための年齢に合わせた栄養システム
CN101451158A (zh) 2007-12-04 2009-06-10 黑龙江大学 副干酪乳杆菌产生的抗菌肽的分离纯化方法
EP2072052A1 (en) 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
ES2542063T3 (es) 2008-01-24 2015-07-30 Nestec S.A. Cápsula que contiene ingredientes nutritivos y procedimiento para el suministro de un líquido nutritivo a partir de dicha cápsula
EP2096115A1 (en) 2008-02-26 2009-09-02 Nestec S.A. Oligosaccharide ingredient
ES2658837T3 (es) 2008-03-14 2018-03-12 Nestec S.A. Mezcla simbiótica
EP2110027A1 (en) 2008-04-01 2009-10-21 Nestec S.A. Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation
FR2930406B1 (fr) 2008-04-29 2011-04-15 Groupe Lactalis Aliment infantile a base de matiere grasse d'origine laitiere
US20110064707A1 (en) 2008-05-27 2011-03-17 Nestec S.A. Probiotics to improve gut microbiota
EP2143341A1 (en) 2008-07-08 2010-01-13 Nestec S.A. Nutritional Composition Containing Oligosaccharide Mixture
WO2009151315A1 (en) 2008-06-13 2009-12-17 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
EP2138187A1 (en) 2008-06-24 2009-12-30 Nestec S.A. Probiotics, secretory IgA and infection
WO2010002241A1 (en) 2008-06-30 2010-01-07 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
EP2143340A1 (en) 2008-07-07 2010-01-13 Nestec S.A. A nutritional composition with free amino acids and structured lipids
US8857317B2 (en) 2008-07-08 2014-10-14 Nestec S.A. Portion-controlled nutrition system and method using capsules
WO2010008272A1 (en) 2008-07-15 2010-01-21 N.V. Nutricia Treatment of gut motility disorders
EP2147678A1 (en) 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
US20110229447A1 (en) 2008-09-19 2011-09-22 Eduardo Schiffrin Nutritional support to prevent or moderate bone marrow paralysis or neutropenia during anti-cancer treatment
EP2168444A1 (en) 2008-09-24 2010-03-31 Nestec S.A. Acidified nutritional formula
ES2771176T3 (es) 2008-11-03 2020-07-06 Nestle Sa Composición nutricional que contiene probióticos y mejora los patrones de sueño
EP2452574A1 (en) 2010-11-15 2012-05-16 Nestec S.A. Age-tailored nutritional formula with particularly adapted caloric density for young infants
AU2009326395B2 (en) 2008-12-08 2015-02-05 Société des Produits Nestlé S.A. Modulation of infant fat mass
RU2011129812A (ru) 2008-12-19 2013-01-27 Нестек С.А. Профилактика и лечение ротавирусной диареи
CA2749254A1 (en) 2009-01-19 2010-07-22 Catherine Mace Nutritional composition for infants
US20100196341A1 (en) 2009-02-05 2010-08-05 Syngen Biotech Co., Ltd. Novel Lactobacillus paracasei subsp. paracasei SG96, a Bacteriostatic Composition Containing the same and Use Thereof
US8846612B2 (en) 2009-04-03 2014-09-30 Nestec S.A. Promotion of healthy catch-up growth
ES2382263T3 (es) 2009-05-11 2012-06-06 Nestec S.A. Prevención y tratamiento de la diarrea alérgica
MX338680B (es) * 2009-05-11 2016-04-27 Nestec Sa Bifidobacterium longum ncc2705 (cncm i-2618) y padecimientos inmunes.
EP2251031A1 (en) 2009-05-12 2010-11-17 Nestec S.A. Lactoferrin and neuronal health and development in the infant gut
EP2251030A1 (en) 2009-05-12 2010-11-17 Nestec S.A. Lactoferrin and brain health and development in infants
WO2010143940A1 (en) 2009-06-12 2010-12-16 N.V. Nutricia Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
MY163002A (en) 2009-08-18 2017-07-31 Nestec Sa A nutritional composition comprising bifidobacterium longum strains and reducing food allergy symptoms, especially in infants and children
US20110070334A1 (en) 2009-09-20 2011-03-24 Nagendra Rangavajla Probiotic Stabilization
EP2308498A1 (en) 2009-09-30 2011-04-13 Nestec S.A. Administration of Bifidobacterium breve during infancy to prevent inflammation later in life
BR112012011294B1 (pt) 2009-11-12 2018-03-20 Nestec S.A. Composição nutricional para administração a um indivíduo
MX346594B (es) 2009-12-29 2017-03-24 Nestec Sa Composiciones nutricionales que comprenden hojuelas de frutas que incluyen acido docosahexaenoico.
EP2545160B1 (en) 2010-03-12 2018-07-18 Compagnie Gervais Danone Lactic acid bacteria for coeliac disease
WO2011121379A1 (en) 2010-03-30 2011-10-06 Assistance Publique - Hopitaux De Paris Use of bifidobacteria for preventing allergy in breastfed infants
WO2011149335A1 (en) 2010-05-25 2011-12-01 N.V. Nutricia Immune imprinting nutritional composition
US20110293784A1 (en) 2010-05-28 2011-12-01 Anja Wittke Milk-based nutritional compositions
WO2011148221A1 (en) 2010-05-28 2011-12-01 Compagnie Gervais Danone Lactic acid bacteria for maturation of the enteric nervous system in infants
US20130149415A1 (en) * 2010-07-15 2013-06-13 Laurent Marchal Use of manganese for enhancing the growth of L.casei in mixed cultures.
CN102021127B (zh) 2010-07-28 2012-05-30 江南大学 一株副干酪乳杆菌及其应用
EP2436389A1 (en) 2010-10-01 2012-04-04 Nestec S.A. Milk-based protein hydrolysates and infant formulae and nutritional compositions made thereof
EP2449891A1 (en) 2010-11-05 2012-05-09 Nestec S.A. Drinking yoghurt preparations containing non-replicating probiotic micro-organisms
EP2449890A1 (en) 2010-11-05 2012-05-09 Nestec S.A. Powdered cereal compositions comprising non-replicating probiotic microorganisms
EP2455094A1 (en) 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect children against gastrointestinal infections
EP2452572A1 (en) 2010-11-15 2012-05-16 Nestec S.A. Age-tailored nutritional formula with particularly adapted caloric density for infants and children
EP2452573A1 (en) 2010-11-15 2012-05-16 Nestec S.A. Age-tailored nutritional composition with animal fats and vegetable fats
EP2465507A1 (en) 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating skin diseases
EP2454948A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
EP2455387A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
EP2465508A1 (en) 2010-11-23 2012-06-20 Nestec S.A. Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
MY160677A (en) 2010-12-06 2017-03-15 Nutricia Nv Fermented infant formula
CN103260430A (zh) 2010-12-08 2013-08-21 雀巢产品技术援助有限公司 包含水解的全谷粒的婴儿谷物产品
EP2465359A1 (en) 2010-12-15 2012-06-20 Nestec S.A. Improved nutritional composition, especially for infants, with particular fat particles
EP2792252B1 (en) 2011-02-10 2018-09-12 Nestec S.A. Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk
CN103582429B (zh) 2011-03-29 2016-06-15 雀巢产品技术援助有限公司 具有降低的钠含量的营养组合物及其制备方法
EP2510932A1 (en) 2011-04-15 2012-10-17 Nestec S.A. Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
EP2514435A1 (en) 2011-04-19 2012-10-24 Nestec S.A. Infant formula for use in the prevention of cardiovascular diseases
EP2522232A1 (en) 2011-05-13 2012-11-14 Nestec S.A. Nutritional products comprising human milk oligosaccharides and methods for manufacture thereof
ES2677850T3 (es) 2011-06-20 2018-08-07 H.J. Heinz Company Brands Llc Composiciones y métodos probióticos
KR101261156B1 (ko) * 2011-07-21 2013-05-07 에스케이씨앤씨 주식회사 비밀키 생성방법 및 이를 적용한 전자장치
ES2691087T3 (es) 2012-06-18 2018-11-23 H.J. Heinz Company Brands Llc Trastornos relacionados con el gluten
CN110651824A (zh) 2013-05-10 2020-01-07 H.J.海因茨品牌有限责任公司 益生菌和使用方法

Also Published As

Publication number Publication date
RU2017129361A3 (pt) 2020-11-05
JP2014516589A (ja) 2014-07-17
CN103997899A (zh) 2014-08-20
WO2012177556A2 (en) 2012-12-27
NZ619099A (en) 2015-08-28
PT2734049T (pt) 2018-07-24
MX352677B (es) 2017-12-04
US11109603B2 (en) 2021-09-07
CA2839524C (en) 2016-05-17
RU2630299C2 (ru) 2017-09-06
US11771102B2 (en) 2023-10-03
TR201809987T4 (tr) 2018-08-27
US10251407B2 (en) 2019-04-09
HK1199694A1 (zh) 2015-07-17
MX2013015175A (es) 2014-09-04
EP2734049B1 (en) 2018-05-02
BR132020021160F1 (pt) 2021-11-30
US10039296B2 (en) 2018-08-07
BR112013032426B1 (pt) 2021-02-09
WO2012177556A3 (en) 2013-05-10
EP3366143A1 (en) 2018-08-29
EP2734049A4 (en) 2015-04-15
AU2012273206A1 (en) 2014-01-16
RU2014101392A (ru) 2015-07-27
AU2012273206B2 (en) 2015-09-24
BR132020021160E2 (pt) 2021-03-23
EP2734049A2 (en) 2014-05-28
RU2748839C2 (ru) 2021-05-31
ES2677850T3 (es) 2018-08-07
CA2839524A1 (en) 2012-12-27
MY171851A (en) 2019-11-04
US20140377238A1 (en) 2014-12-25
RU2017129361A (ru) 2019-02-20
US20210259264A1 (en) 2021-08-26
US20170202231A1 (en) 2017-07-20
MY187589A (en) 2021-09-30
US20190281846A1 (en) 2019-09-19
CN103997899B (zh) 2016-04-20
DK2734049T3 (en) 2018-07-30
PL2734049T3 (pl) 2018-10-31

Similar Documents

Publication Publication Date Title
BR112013032426A2 (pt) composições probióticas e métodos
IL271305B (en) Anti-ntb–a antibodies and related compositions and methods
DK3495392T3 (da) Anti-cgrp-sammensætninger og anvendelse deraf
BR112013023776A2 (pt) composição e abertura vedada com selante
BR112014012137A2 (pt) anticorpos anti-fgfr2 e suas utilizações
BR112013022112A2 (pt) composição
BR112013022102A2 (pt) composição
DK2686017T3 (da) Oftalmisk sammensætning
BR112014004395A2 (pt) composição
BR112014010450A2 (pt) composição e método
DK2900805T3 (da) Probiotiske og præbiotiske sammensætninger
BR112013014644A2 (pt) composição farmacêutica e complexo
BR112014006291A2 (pt) composição e utilização da composição
BR112014009963A2 (pt) composição dietética
BR112013033808A2 (pt) composição
BR112013022766A2 (pt) método de administração de d-pirfenidona e kit
DK2661274T3 (da) Sammensætninger og fremgangsmåder med aloepolysaccharider
BR112014010860A2 (pt) composição e método
BR112014007030A2 (pt) composição
EP2668044A4 (en) COMPOSITIONS AND THEIR USE
DK2672837T4 (da) Ernæringssammensætning og anvendelser deraf
ZA201308892B (en) Compositions and methods
EP2766357A4 (en) MESOBILIVERDINE COMPOSITIONS AND METHOD THEREFOR
BR112014010769A2 (pt) métodos e composições para neuroproteção
BR112013019707A2 (pt) métodos e composições antinematóides

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Ipc: A23C 9/123 (2006.01), A23C 9/127 (2006.01), A23L 7

B25A Requested transfer of rights approved

Owner name: H.J. HEINZ COMPANY BRANDS LLC (US)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/06/2012, OBSERVADAS AS CONDICOES LEGAIS.